APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Genetic Screening Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pet Genetic Screening Platform Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchPet Genetic Screening Platform Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Genetic Screening Platform Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Pet Genetic Screening Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Genetic Screening Platform Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Pet Genetic Screening Platform Market Analysis and Forecast 2026-2032243 pages · $4,950 USD

Market perspective

The global Pet Genetic Screening Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pet Genetic Screening Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Genetic Screening Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Genetic Screening Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pet Genetic Screening Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pet Genetic Screening Platform market include Wisdom Panel, Embark Veterinary, Basepaws, Orivet Genetic Pet Care, Paw Print Genetics, Animal Genetics, VetGen, Antagene and Laboklin, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pet Genetic Screening Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Genetic Screening Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Genetic Screening Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pet Genetic Screening Platform market.

Pet Genetic Screening Platform Segment by Company

Wisdom Panel

Embark Veterinary

Basepaws

Orivet Genetic Pet Care

Paw Print Genetics

Animal Genetics

VetGen

Antagene

Laboklin

UC Davis

OptiGen

VHLGenetics

Sinogene

PawKnows

Circle Dog

BGI Genomics

GENEWIZ

Pet Genetic Screening Platform Segment by Type

Single Gene Defect Screening Platform

Whole Genome Health Risk Screening Platform

Pet Genetic Screening Platform Segment by Application

Medical Institutions

Pet Breeding Companies

Others

Pet Genetic Screening Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pet Genetic Screening Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pet Genetic Screening Platform key companies, revenue, market share, and recent developments.

3. To split the Pet Genetic Screening Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pet Genetic Screening Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pet Genetic Screening Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Pet Genetic Screening Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Genetic Screening Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Genetic Screening Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Genetic Screening Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Genetic Screening Platform industry.

Chapter 3: Detailed analysis of Pet Genetic Screening Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pet Genetic Screening Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pet Genetic Screening Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pet Genetic Screening Platform Industry Trends Table 2. Pet Genetic Screening Platform Industry Drivers Table 3. Pet Genetic Screening Platform Industry Opportunities and Challenges Table 4. Pet Genetic Screening Platform Industry Restraints Table 5. Global Pet Genetic Screening Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pet Genetic Screening Platform Revenue Share by Company (2021-2026) Table 7. Global Pet Genetic Screening Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pet Genetic Screening Platform Key Company Manufacturing Base & Headquarters Table 9. Global Pet Genetic Screening Platform Company, Product Type & Application Table 10. Global Pet Genetic Screening Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pet Genetic Screening Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Single Gene Defect Screening Platform Table 15. Significant Companies of Whole Genome Health Risk Screening Platform Table 16. Global Pet Genetic Screening Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pet Genetic Screening Platform Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pet Genetic Screening Platform Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pet Genetic Screening Platform Sales Value Share by Type (2021-2026) Table 20. Global Pet Genetic Screening Platform Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical Institutions Table 22. Significant Companies of Pet Breeding Companies Table 23. Significant Companies of Others Table 24. Global Pet Genetic Screening Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pet Genetic Screening Platform Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Pet Genetic Screening Platform Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Pet Genetic Screening Platform Sales Value Share by Application (2021-2026) Table 28. Global Pet Genetic Screening Platform Sales Value Share by Application (2027-2032) Table 29. Global Pet Genetic Screening Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pet Genetic Screening Platform Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Pet Genetic Screening Platform Sales Value Share by Region (2021-2026) Table 32. Global Pet Genetic Screening Platform Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Pet Genetic Screening Platform Sales Value Share by Region (2027-2032) Table 34. Global Pet Genetic Screening Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pet Genetic Screening Platform Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Pet Genetic Screening Platform Sales Value Market Share by Country (2021-2026) Table 37. Global Pet Genetic Screening Platform Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Pet Genetic Screening Platform Sales Value Market Share by Country (2027-2032) Table 39. Wisdom Panel Company Information Table 40. Wisdom Panel Business Overview Table 41. Wisdom Panel Pet Genetic Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Wisdom Panel Pet Genetic Screening Platform Product Portfolio Table 43. Wisdom Panel Recent Development Table 44. Embark Veterinary Company Information Table 45. Embark Veterinary Business Overview Table 46. Embark Veterinary Pet Genetic Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Embark Veterinary Pet Genetic Screening Platform Product Portfolio Table 48. Embark Veterinary Recent Development Table 49. Basepaws Company Information Table 50. Basepaws Business Overview Table 51. Basepaws Pet Genetic Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Basepaws Pet Genetic Screening Platform Product Portfolio Table 53. Basepaws Recent Development Table 54. Orivet Genetic Pet Care Company Information Table 55. Orivet Genetic Pet Care Business Overview Table 56. Orivet Genetic Pet Care Pet Genetic Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Orivet Genetic Pet Care Pet Genetic Screening Platform Product Portfolio Table 58. Orivet Genetic Pet Care Recent Development Table 59. Paw Print Genetics Company Information Table 60. Paw Print Genetics Business Overview Table 61. Paw Print Genetics Pet Genetic Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Paw Print Genetics Pet Genetic Screening Platform Product Portfolio Table 63. Paw Print Genetics Recent Development Table 64. Animal Genetics Company Information Table 65. Animal Genetics Business Overview Table 66. Animal Genetics Pet Genetic Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Animal Genetics Pet Genetic Screening Platform Product Portfolio Table 68. Animal Genetics Recent Development Table 69. VetGen Company Information Table 70. VetGen Business Overview Table 71. VetGen Pet Genetic Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. VetGen Pet Genetic Screening Platform Product Portfolio Table 73. VetGen Recent Development Table 74. Antagene Company Information Table 75. Antagene Business Overview Table 76. Antagene Pet Genetic Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Antagene Pet Genetic Screening Platform Product Portfolio Table 78. Antagene Recent Development Table 79. Laboklin Company Information Table 80. Laboklin Business Overview Table 81. Laboklin Pet Genetic Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Laboklin Pet Genetic Screening Platform Product Portfolio Table 83. Laboklin Recent Development Table 84. UC Davis Company Information Table 85. UC Davis Business Overview Table 86. UC Davis Pet Genetic Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. UC Davis Pet Genetic Screening Platform Product Portfolio Table 88. UC Davis Recent Development Table 89. OptiGen Company Information Table 90. OptiGen Business Overview Table 91. OptiGen Pet Genetic Screening Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. OptiGen Pet Genetic Screening Platform Product Portfolio Table 93. OptiGen Recent Development Table 94. VHLGenetics Company Information Table 95. VHLGenetics Business Overview Table 96. VHLGenetics Pet Genetic Screening Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. VHLGenetics Pet Genetic Screening Platform Product Portfolio Table 98. VHLGenetics Recent Development Table 99. Sinogene Company Information Table 100. Sinogene Business Overview Table 101. Sinogene Pet Genetic Screening Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Sinogene Pet Genetic Screening Platform Product Portfolio Table 103. Sinogene Recent Development Table 104. PawKnows Company Information Table 105. PawKnows Business Overview Table 106. PawKnows Pet Genetic Screening Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. PawKnows Pet Genetic Screening Platform Product Portfolio Table 108. PawKnows Recent Development Table 109. Circle Dog Company Information Table 110. Circle Dog Business Overview Table 111. Circle Dog Pet Genetic Screening Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Circle Dog Pet Genetic Screening Platform Product Portfolio Table 113. Circle Dog Recent Development Table 114. BGI Genomics Company Information Table 115. BGI Genomics Business Overview Table 116. BGI Genomics Pet Genetic Screening Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. BGI Genomics Pet Genetic Screening Platform Product Portfolio Table 118. BGI Genomics Recent Development Table 119. GENEWIZ Company Information Table 120. GENEWIZ Business Overview Table 121. GENEWIZ Pet Genetic Screening Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. GENEWIZ Pet Genetic Screening Platform Product Portfolio Table 123. GENEWIZ Recent Development Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Pet Genetic Screening Platform Product Image Figure 2. Global Pet Genetic Screening Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Genetic Screening Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Genetic Screening Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Single Gene Defect Screening Platform Image Figure 8. Whole Genome Health Risk Screening Platform Image Figure 9. Global Pet Genetic Screening Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pet Genetic Screening Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pet Genetic Screening Platform Sales Value Share by Type (2021-2032) Figure 12. Medical Institutions Image Figure 13. Pet Breeding Companies Image Figure 14. Others Image Figure 15. Global Pet Genetic Screening Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pet Genetic Screening Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pet Genetic Screening Platform Sales Value Share by Application (2021-2032) Figure 18. Global Pet Genetic Screening Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Pet Genetic Screening Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Pet Genetic Screening Platform Sales Value (2021-2032) & (US$ Million) Figure 21. North America Pet Genetic Screening Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Pet Genetic Screening Platform Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Pet Genetic Screening Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Pet Genetic Screening Platform Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Pet Genetic Screening Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Pet Genetic Screening Platform Sales Value (2021-2032) & (US$ Million) Figure 27. South America Pet Genetic Screening Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Pet Genetic Screening Platform Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Pet Genetic Screening Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Single Gene Defect Screening Platform
  • Whole Genome Health Risk Screening Platform
Applications
  • Medical Institutions
  • Pet Breeding Companies
  • Others
Companies covered
  • Wisdom Panel
  • Embark Veterinary
  • Basepaws
  • Orivet Genetic Pet Care
  • Paw Print Genetics
  • Animal Genetics
  • VetGen
  • Antagene
  • Laboklin
  • UC Davis
  • OptiGen
  • VHLGenetics
  • Sinogene
  • PawKnows
  • Circle Dog
  • BGI Genomics
  • GENEWIZ

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pet Genetic Screening Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pet Genetic Screening Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pet Genetic Screening Platform Market Dynamics
  1. 2.1 Pet Genetic Screening Platform Industry Trends
  2. 2.2 Pet Genetic Screening Platform Industry Drivers
  3. 2.3 Pet Genetic Screening Platform Industry Opportunities and Challenges
  4. 2.4 Pet Genetic Screening Platform Industry Restraints
3 Pet Genetic Screening Platform Market by Company
  1. 3.1 Global Pet Genetic Screening Platform Company Revenue Ranking in 2025
  2. 3.2 Global Pet Genetic Screening Platform Revenue by Company (2021-2026)
  3. 3.3 Global Pet Genetic Screening Platform Company Ranking (2024-2026)
  4. 3.4 Global Pet Genetic Screening Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Pet Genetic Screening Platform Company Product Type and Application
  6. 3.6 Global Pet Genetic Screening Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pet Genetic Screening Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pet Genetic Screening Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pet Genetic Screening Platform Market by Type
  1. 4.1 Pet Genetic Screening Platform Type Introduction
  2. 4.1.1 Single Gene Defect Screening Platform
  3. 4.1.2 Whole Genome Health Risk Screening Platform
  4. 4.2 Global Pet Genetic Screening Platform Sales Value by Type
  5. 4.2.1 Global Pet Genetic Screening Platform Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pet Genetic Screening Platform Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pet Genetic Screening Platform Sales Value Share by Type (2021-2032)
5 Pet Genetic Screening Platform Market by Application
  1. 5.1 Pet Genetic Screening Platform Application Introduction
  2. 5.1.1 Medical Institutions
  3. 5.1.2 Pet Breeding Companies
  4. 5.1.3 Others
  5. 5.2 Global Pet Genetic Screening Platform Sales Value by Application
  6. 5.2.1 Global Pet Genetic Screening Platform Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Genetic Screening Platform Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pet Genetic Screening Platform Sales Value Share by Application (2021-2032)
6 Pet Genetic Screening Platform Regional Value Analysis
  1. 6.1 Global Pet Genetic Screening Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Genetic Screening Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pet Genetic Screening Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pet Genetic Screening Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pet Genetic Screening Platform Sales Value (2021-2032)
  7. 6.3.2 North America Pet Genetic Screening Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pet Genetic Screening Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Pet Genetic Screening Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pet Genetic Screening Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pet Genetic Screening Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pet Genetic Screening Platform Sales Value (2021-2032)
  16. 6.6.2 South America Pet Genetic Screening Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pet Genetic Screening Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pet Genetic Screening Platform Sales Value Share by Country, 2025 VS 2032
7 Pet Genetic Screening Platform Country-level Value Analysis
  1. 7.1 Global Pet Genetic Screening Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pet Genetic Screening Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pet Genetic Screening Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pet Genetic Screening Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pet Genetic Screening Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pet Genetic Screening Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pet Genetic Screening Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wisdom Panel
  2. 8.1.1 Wisdom Panel Company Information
  3. 8.1.2 Wisdom Panel Business Overview
  4. 8.1.3 Wisdom Panel Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wisdom Panel Pet Genetic Screening Platform Product Portfolio
  6. 8.1.5 Wisdom Panel Recent Developments
  7. 8.2 Embark Veterinary
  8. 8.2.1 Embark Veterinary Company Information
  9. 8.2.2 Embark Veterinary Business Overview
  10. 8.2.3 Embark Veterinary Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Embark Veterinary Pet Genetic Screening Platform Product Portfolio
  12. 8.2.5 Embark Veterinary Recent Developments
  13. 8.3 Basepaws
  14. 8.3.1 Basepaws Company Information
  15. 8.3.2 Basepaws Business Overview
  16. 8.3.3 Basepaws Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Basepaws Pet Genetic Screening Platform Product Portfolio
  18. 8.3.5 Basepaws Recent Developments
  19. 8.4 Orivet Genetic Pet Care
  20. 8.4.1 Orivet Genetic Pet Care Company Information
  21. 8.4.2 Orivet Genetic Pet Care Business Overview
  22. 8.4.3 Orivet Genetic Pet Care Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Orivet Genetic Pet Care Pet Genetic Screening Platform Product Portfolio
  24. 8.4.5 Orivet Genetic Pet Care Recent Developments
  25. 8.5 Paw Print Genetics
  26. 8.5.1 Paw Print Genetics Company Information
  27. 8.5.2 Paw Print Genetics Business Overview
  28. 8.5.3 Paw Print Genetics Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Paw Print Genetics Pet Genetic Screening Platform Product Portfolio
  30. 8.5.5 Paw Print Genetics Recent Developments
  31. 8.6 Animal Genetics
  32. 8.6.1 Animal Genetics Company Information
  33. 8.6.2 Animal Genetics Business Overview
  34. 8.6.3 Animal Genetics Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Animal Genetics Pet Genetic Screening Platform Product Portfolio
  36. 8.6.5 Animal Genetics Recent Developments
  37. 8.7 VetGen
  38. 8.7.1 VetGen Company Information
  39. 8.7.2 VetGen Business Overview
  40. 8.7.3 VetGen Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 VetGen Pet Genetic Screening Platform Product Portfolio
  42. 8.7.5 VetGen Recent Developments
  43. 8.8 Antagene
  44. 8.8.1 Antagene Company Information
  45. 8.8.2 Antagene Business Overview
  46. 8.8.3 Antagene Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Antagene Pet Genetic Screening Platform Product Portfolio
  48. 8.8.5 Antagene Recent Developments
  49. 8.9 Laboklin
  50. 8.9.1 Laboklin Company Information
  51. 8.9.2 Laboklin Business Overview
  52. 8.9.3 Laboklin Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Laboklin Pet Genetic Screening Platform Product Portfolio
  54. 8.9.5 Laboklin Recent Developments
  55. 8.10 UC Davis
  56. 8.10.1 UC Davis Company Information
  57. 8.10.2 UC Davis Business Overview
  58. 8.10.3 UC Davis Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 UC Davis Pet Genetic Screening Platform Product Portfolio
  60. 8.10.5 UC Davis Recent Developments
  61. 8.11 OptiGen
  62. 8.11.1 OptiGen Company Information
  63. 8.11.2 OptiGen Business Overview
  64. 8.11.3 OptiGen Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 OptiGen Pet Genetic Screening Platform Product Portfolio
  66. 8.11.5 OptiGen Recent Developments
  67. 8.12 VHLGenetics
  68. 8.12.1 VHLGenetics Company Information
  69. 8.12.2 VHLGenetics Business Overview
  70. 8.12.3 VHLGenetics Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 VHLGenetics Pet Genetic Screening Platform Product Portfolio
  72. 8.12.5 VHLGenetics Recent Developments
  73. 8.13 Sinogene
  74. 8.13.1 Sinogene Company Information
  75. 8.13.2 Sinogene Business Overview
  76. 8.13.3 Sinogene Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sinogene Pet Genetic Screening Platform Product Portfolio
  78. 8.13.5 Sinogene Recent Developments
  79. 8.14 PawKnows
  80. 8.14.1 PawKnows Company Information
  81. 8.14.2 PawKnows Business Overview
  82. 8.14.3 PawKnows Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 PawKnows Pet Genetic Screening Platform Product Portfolio
  84. 8.14.5 PawKnows Recent Developments
  85. 8.15 Circle Dog
  86. 8.15.1 Circle Dog Company Information
  87. 8.15.2 Circle Dog Business Overview
  88. 8.15.3 Circle Dog Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Circle Dog Pet Genetic Screening Platform Product Portfolio
  90. 8.15.5 Circle Dog Recent Developments
  91. 8.16 BGI Genomics
  92. 8.16.1 BGI Genomics Company Information
  93. 8.16.2 BGI Genomics Business Overview
  94. 8.16.3 BGI Genomics Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BGI Genomics Pet Genetic Screening Platform Product Portfolio
  96. 8.16.5 BGI Genomics Recent Developments
  97. 8.17 GENEWIZ
  98. 8.17.1 GENEWIZ Company Information
  99. 8.17.2 GENEWIZ Business Overview
  100. 8.17.3 GENEWIZ Pet Genetic Screening Platform Revenue and Gross Margin (2021-2026)
  101. 8.17.4 GENEWIZ Pet Genetic Screening Platform Product Portfolio
  102. 8.17.5 GENEWIZ Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst